UK to Offer Alternative to AstraZeneca Vaccine as Blood Clots Deaths Rise to 49

A dose of the AstraZeneca COVID-19 vaccine is prepared in a vaccination centre at Newmarket Racecourse, amid the coronavirus disease outbreak in Newmarket, Britain, on March 26, 2021. Andrew Couldridge/Reuters

The UK health authorities said on Friday that people under 40 will be offered an alternative to the Oxford/AstraZeneca CCP virus vaccine.

According to the UK’s medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA), 49 people have died after developing blood clots following vaccination with the AstraZeneca shot.